Audentes Therapeutics Appoints Jennifer Jarrett to Board of Directors
PR Newswire (press release) SAN FRANCISCO, June 13, 2017 /PRNewswire/ — Audentes Therapeutics, Inc. (Nasdaq: BOLD), a biotechnology company focused on developing and … |
June 14, 2017 at 07:27AM
from
No comments:
Post a Comment